These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 349573)

  • 1. Reversal of platelet aggregation by prostacyclin.
    Gryglewski RJ; Korbut R; Ocetkiewicz A
    Pharmacol Res Commun; 1978 Feb; 10(2):185-9. PubMed ID: 349573
    [No Abstract]   [Full Text] [Related]  

  • 2. De-aggregatory action of prostacyclin in vivo and its enhancement by theophylline.
    Gryglewski RJ; Korbut R; Ocetkiewicz A
    Prostaglandins; 1978 Apr; 15(4):637-44. PubMed ID: 353903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A biphasic effect of prostacyclin (PGI2) on platelet aggregation.
    Jørgensen KA; Dyerberg J; Stoffersen E
    Thromb Res; 1980 Sep; 19(6):877-81. PubMed ID: 6258262
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of prostacyclin, 6-keto-PGF1 alpha PGF2 alpha and 15[S]15-methyl-PGF2 alpha on platelet aggregation in vitro.
    Marmo E; Somma A; Ottavo R; Vairo G; Spaziante G; DiMezza F; Paone G
    J Med; 1981; 12(2-3):97-108. PubMed ID: 7024451
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostaglandins E1 and E2, but neither prostacyclin nor prostaglandin D2 have anti-aggregating activity in chicken blood.
    Bult H; Wechsung E; Houvenaghel A; Herman AG
    Arch Int Pharmacodyn Ther; 1981 Feb; 249(2):306-8. PubMed ID: 7013724
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of prostacyclin on platelet-activating factor induced rabbit and platelet aggregation.
    Bussolino F; Camussi G
    Prostaglandins; 1980 Nov; 20(5):781-91. PubMed ID: 6258196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species.
    Whittle BJ; Moncada S; Vane JR
    Prostaglandins; 1978 Sep; 16(3):373-88. PubMed ID: 364545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostacyclin (PGI2) and thromboxane A2 interaction in vivo. Regulation by aspirin and relationship with anti-thrombotic therapy.
    Korbut R; Moncada S
    Thromb Res; 1978 Sep; 13(3):489-500. PubMed ID: 369028
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of prostacyclin on platelet aggregation and disaggregation in vivo.
    Martin JF; Suggett AJ; Leach E; Moncada S
    Thromb Res; 1980 Jun; 18(5):749-51. PubMed ID: 6998043
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-aggregatory effect of prostacyclin (PGI2) in vivo.
    Bayer BL; Blass KE; Förster W
    Br J Pharmacol; 1979 May; 66(1):10-2. PubMed ID: 378308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro inhibition by endotoxin of the anti-aggregatory action of prostacyclin produced by aortic rings.
    Bult H; Herman AG
    Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):335-6. PubMed ID: 361006
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of human platelet aggregation by stable analogs of prostacyclin.
    Togna G; GAndolfi C; Andreoni A; Fumagalli A; Passarotti C; Faustini F; Patrono C
    Pharmacol Res Commun; 1977 Nov; 9(10):909-16. PubMed ID: 343117
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of prostacyclin (PGT2) on platelet behaviour. Thrombus formation in vivo and bleeding time.
    Ubatuba FB; Moncada S; Vane JR
    Thromb Haemost; 1979 Apr; 41(2):425-35. PubMed ID: 382434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
    Smith JB; Araki H; Lefer AM
    Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostacyclin and the vascular endothelium.
    Moncada S; Vane JR
    Bull Eur Physiopathol Respir; 1981; 17(4):687-701. PubMed ID: 7034824
    [No Abstract]   [Full Text] [Related]  

  • 16. Carbacyclin--a potent stable prostacyclin analogue for the inhibition of platelet aggregation.
    Whittle BJ; Moncada S; Whiting F; Vane JR
    Prostaglandins; 1980 Apr; 19(4):605-27. PubMed ID: 6992234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergism between prostacyclin (PGI2) and prazosin on human platelet aggregation.
    Moore PK
    Thromb Haemost; 1982 Feb; 47(1):76. PubMed ID: 7041326
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prostacyclin--inhibitory effect on thrombocyte aggregation on the vascular wall in vivo?].
    Sinzinger H; Silberbauer K; Winter M
    Vasa; 1978; 7(4):350-9. PubMed ID: 364866
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the activities of prostacyclin and its stable analogs on the platelet aggregation and cardiovascular systems.
    Kawasaki A; Ishii K; Wakitani K; Tsuboshima M
    Adv Prostaglandin Thromboxane Res; 1980; 6():331-6. PubMed ID: 6992531
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelet sensitivity to prostacyclin in pregnancy and uterine cancer.
    Briel RC; Lippert TH
    Eur J Obstet Gynecol Reprod Biol; 1981 Jun; 12(1):19-23. PubMed ID: 7018952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.